Press Releases
ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure
Legal Focus on Drug Efficacy: Partner Reed Kathrein Scrutinizing Alleged Misrepresentations of Efzofitimod's Steroid-Tapering Capability Legal Focus on Drug Efficacy: Partner Reed Kathrein Scrutinizing Alleged Misrepresentations of Efzofitimod's Steroid-Tapering Capability
AMEEREX Signs MOU to Acquire 45.6 million-Ounce Silver-Gold Project in Nevada, Expanding Its North American Precious-Metals Portfolio
ATLANTA, GA AND DOHA, QATAR / ACCESS Newswire / December 6, 2025 / Ameerex Corporation (OTC:HIRU) ("Ameerex" or the "Company"), a natural-resources group owned and managed by high-profile Qatari investors, announces that it has signed a Memorandum of Understanding (MOU) to acquire a 100% interest in the Corcoran Canyon Silver-Gold Project in Nye County, Nevada. The NI 43-101 Technical Report for Corcoran Canyon outlines a substantial Inferred Mineral Resource totaling approximately 45.6 million silver-equivalent ounces (AgEq), comprising: ~39.0M AgEq ounces pit-constrained ~6.66M AgEq ounces underground The deposit is a low-sulfidation epithermal silver-gold system supported by extensive historical drilling, metallurgical work, and clear structural controls...
Worthington Steel Issues Statement Regarding Klöckner & Co SE
COLUMBUS, Ohio--(BUSINESS WIRE)--Worthington Steel, Inc. (NYSE: WS) today issued the following statement: We confirm that we are in negotiations with Klöckner & Co SE about a potential voluntary public takeover offer of Klöckner & Co SE. No investment decision has been made now and the discussions may not result in a transaction. The Company does not intend to comment further. About Worthington Steel Worthington Steel (NYSE:WS) is a metals processor that partners with customers to deliv...
Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs
First disclosure of PRT12396, a JAK2V617F-selective JH2 inhibitor demonstrates disease modifying potential in myeloproliferative neoplasms
Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting
ROCKVILLE, Md. and SUZHOU, China, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization novel, differentiated therapies to address unmet medical needs in cancer, announced that it has presented an oral report featuring the latest results from a registrational Phase II study conducted in China of Lisaftoclax (APG-2575), a key drug candidate in the Company‘s pipeline, as a monotherapy in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who had failed Bruton's tyrosine kinase inhibitors (BTKis), at the 67th American Society of Hematology (ASH) Annual Meeting, being held in Orlando, FL. Data from this pivotal trial supported the NDA approval that was granted to Lisaftoclax by China's National Medical Products Administration (NMPA) in July 2025...
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
Media Release COPENHAGEN, Denmark; December 6, 2025 New two- and three-year EPCORE NHL-2 follow-up data evaluating epcoritamab in combination with standard of care regimens demonstrate remission in patients with DLBCL and FL Latest EPCORE DLBCL-3 trial results show encouraging overall response and complete response rates for epcoritamab monotherapy in newly-diagnosed, elderly patients with DLBCL Data presented at the 67 th Annual Meeting and Exposition of the American Society of Hematology (ASH) reinforce the potential utility of epcoritamab in earlier lines of therapy with a fixed treatment duration Genmab A/S (Nasdaq: GMAB) today announced updated results from two ongoing clinical trials evaluating the efficacy and safety of epcoritamab-bysp, a T-cell engaging antibody administered subcutaneously, as a monotherapy and in combination with other standard of care treatments in adult patients with diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) . Results from two arms of the EPCORE NHL-2 trial, evaluating first-line, fixed-treatment duration epcoritamab in combination with chemotherapies, demonstrated overall response rates (ORR) of 93% (Arm 8) and 98% (Arm 1) in patients with newly-diagnosed DLBCL, while a third arm (Arm 3) demonstrated a three-year overall survival (OS) rate of 96% in patients with FL following first-line combination treatment...
Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematology (ASH)
-- Bezuclastinib achieves clear clinical benefit across all symptom domains including significant improvements on 11 individual symptoms plus the most severe symptom at baseline -- -- Bezuclastinib demonstrates that reducing objective measures of disease, including serum tryptase, correlates with improvement in symptom severity; the first time this has been shown in NonAdvSM patients --
Earlier use of CARVYKTI® demonstrated lasting treatment-free remissions at 2.5 years in patients with relapsed or refractory multiple myeloma
Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression and treatment-free following a single infusion as early as second line Data suggest stronger immune fitness in earlier lines may be associated with longer progression free survival ORLANDO, Fla. , Dec. 6, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today updated results from the Phase 3 CARTITUDE-4 study supporting durable treatment-free remissions as early as second line treatment with CARVYKTI (ciltacabtagene autoleucel; cilta-cel)...
Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition
Objective response rate (ORR) of 83% including two complete responses in CLL patients in Phase 1a study with median progression free survival (PFS) of 22.1 months across all doses tested
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera
NEWARK, Calif. & OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide's efficacy and safety and demonstrate du...
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) today announced updated results from two ongoing clinical trials evaluating the efficacy and safety of epcoritamab-bysp, a T-cell engaging antibody administered subcutaneously, as a monotherapy and in combination with other standard of care treatments in adult patients with diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). Results from two arms of the EPCORE NHL-2 trial, evaluating first-line, fixed-treatment dur...
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting
OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. The results were presented by Ionis Pharmaceuticals...
MAREX URGENT DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges Marex Stockholders to Contact the Firm Before December 8th Deadline
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Marex (MRX) To Contact Him Directly To Discuss Their Options If you purchased or acquired Marex securities between May 16, 2024 and August 5, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648...
Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited
Viatris to Receive $400 Million in Cash and $415 Million in Equity Shares of Biocon Limited Transaction Accelerates the Expiration of Biosimilars Non-Compete Restrictions PITTSBURGH , Dec. 6, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that it has entered into definitive agreements with Biocon Limited ("Biocon") for the sale of Viatris' equity stake in Biocon Biologics Limited ("Biocon Biologics"). Under the definitive agreements, Biocon will acquire all of Viatris' convertible preferred equity in Biocon Biologics for total consideration of $815 million, consisting of $400 million in cash and $415 million in newly issued equity shares of Biocon...
Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced growing interventional use of its clonoSEQ test among the 90 abstracts featuring clonoSEQ data at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place Dec. 6–9, 2025, in Orlando. Notably, 17 abstracts utilizing Adaptive's clonoSEQ test exemplify how next-generation sequencing-based measurable residual disease (MRD) status is guiding clinical actions to improve blood cancer patient care...
Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial to evaluate ARV-393 plus glofitamab as a chemotherapy-free combination approach in diffuse large B-cell lymphoma (DLBCL); initiation expected in 2026 – NEW HAVEN, Conn., Dec. 06, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced preclinical data for ARV-393, a PROTAC BCL6 degrader, in combination with glofitamab, a CD20×CD3 bispecific antibody, presented in a poster at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, held December 6–9, 2025, in Orlando, Florida...
Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting
Updated Data from 31 Adult and Adolescent SCD Patients Treated with risto-cel (Formerly BEAM-101) Show Mean He moglobin F (HbF) Induction of >60%, Hemoglobin S (HbS) Reduction to
Bicara Therapeutics' Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety profile comparable to 1500mg QW dose, further derisking pivotal FORTIFI-HN01 study interim analysis
Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
WATERTOWN, Mass., Dec. 06, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today presented positive initial data from the RALLY-MF Phase 2 trial of DISC-0974 in anemia of MF at the ASH Annual Meeting in Orlando, FL. The data demonstrated that treatment with DISC-0974 resulted in substantial reductions in hepcidin and increases in iron levels translating to positive impact on clinically meaningful measures of anemia across a broad range of patient types...
Aptose's Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations
Aptose's Tuspetinib Triple Drug Therapy Featured at 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Population
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with seve...
Douglas Emmett Declares Quarterly Cash Dividend
SANTA MONICA, Calif.--(BUSINESS WIRE)--Douglas Emmett, Inc. (NYSE: DEI), a real estate investment trust (REIT), announced today that its Board of Directors has declared a quarterly cash dividend on each share of its common stock of $0.19, or $0.76 on an annualized basis, to be paid on January 15, 2026 to shareholders of record as of December 31, 2025. About Douglas Emmett, Inc. Douglas Emmett, Inc. (DEI) is a fully integrated, self-administered and self-managed real estate investment trust (REI...
Plurilock Announces Appointment of New CFO
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - Plurilock Security Inc. (TSXV: PLUR) (OTCQB: PLCKF) ("Plurilock" or the "Company"), a global cybersecurity systems integrator, announces the promotion of Veera Singh to Chief Financial Officer, effective January 9, 2026. Mrs. Singh, who currently serves as Vice President of Finance, has been a key contributor to Plurilock's growth and operational maturity for more than four years...
ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025
Highly differentiated 1L preliminary systemic activity of 67% ORR and 100% intracranial ORR (by BICR-RANO), including in patients with active brain metastases
Northern Dynasty Provides Update on Board Search and Audit & Risk Committee Composition
VANCOUVER, BC / ACCESS Newswire / December 5, 2025 / Northern Dynasty Minerals Ltd. (TSX:NDM)(NYSE American:NAK) ("Northern Dynasty" or the "Company") is pleased to provide an update on the process undertaken by its Board of Directors (the "Board") to replace Christian Milau, who resigned from the Board in September 2025...
MiMedia Engages Canaccord Genuity as a Financial Advisor, DS Market Solutions Inc. for Market-Making Services and Announces a Change in Directors
New York, New York--(Newsfile Corp. - December 5, 2025) - MiMedia Holdings Inc. (TSXV: MIM) (OTCQB: MIMDF) (FSE: KH3) ("MiMedia" or the "Company") is pleased to announce that it has entered into an advisory services agreement (the "Advisory Agreement") with Canaccord Genuity Corp. ("Canaccord"), pursuant to which Canaccord will serve as the Company's financial advisor and provide certain fiscal advisory services to the Company in connection with strategic capital markets initiatives. Chris Giordano, President and CEO of MiMedia stated, "We are pleased to welcome Canaccord as the Company's financial advisor, recognizing their extensive expertise and proven capabilities in financial strategy and capital markets...
Prospect Ridge Announces Closing of Flow-Through Unit Private Placement
NOT FOR DISTRIBUTION OR DISSEMINATION TO THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / December 5, 2025 / Prospect Ridge Resources Corp. (the "Company" or "Prospect Ridge") (CSE:PRR)(OTCQB:PRRSF)(FRA:OED) is pleased to announce that it has closed the third and final tranche of its non-brokered private placement of $0.12 flow-through units announced on October 17, 2025 (see news release for details), issuing 416,667 flow-through units for gross proceeds of $50,000.00. All securities issued in the third tranche are subject to a statutory hold period expiring on April 4, 2026, and no finder fees were paid...
Copper Quest Closes $1,927,000 Private Placement
// Not for distribution to the United States newswire services or for dissemination in the United States //
Nortec Provides an Update on Proposed Barker Bay Gold Property Acquisition
Toronto, Ontario--(Newsfile Corp. - December 5, 2025) - Nortec Minerals Corp. (TSXV: NVT) ("Nortec" or the "Company") is pleased to report on the status of the proposed acquisition of the Barker Bay Gold Property (the "Acquisition") as announced via news release on November 5, 2025. The Company received conditional approval for the Acquisition from the TSX Venture Exchange (the "TSXV") on December 4, 2025...
BRAEMAR HOTELS & RESORTS SHIFTS 2025 ANNUAL MEETING TO VIRTUAL FORMAT
DALLAS , Dec. 5, 2025 /PRNewswire/ -- Braemar Hotels & Resorts Inc. (NYSE: BHR) (the "Company") today announced that the location of its 2025 Annual Meeting of Stockholders ("Annual Meeting") will be changed from an in-person meeting to a virtual format via a live online webcast. As previously announced, the Annual Meeting will be held on Monday, Dec. 15, 2025 at 9:00 a.m...
Lattice Wins 2025 Global Semiconductor Alliance Award
HILLSBORO, Ore.--(BUSINESS WIRE)---- $LSCC #Edge--Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company' at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconduct...
Dynasty Gold Closes Non-Brokered Financing
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - Dynasty Gold Corp. (TSXV: DYG) (FSE: D5G1) (OTC Pink: DGDCF) ("Dynasty" or the "Company") is pleased to announce that, subject to Exchange approval, it intends to close a non-brokered private placement for total gross proceeds of $751,800, combining both non-flow-through and flow-through units. The company builds on its existing cash reserve of over $3 million and is now fully funded for its current drill program and the 2026 exploration program...
HNI Corporation Announces Expiration and Final Results of Exchange Offer
MUSCATINE, Iowa, Dec. 05, 2025 (GLOBE NEWSWIRE) -- On August 4, 2025, HNI Corporation (NYSE: HNI; “HNI”) announced a definitive agreement to acquire Steelcase, Inc. (NYSE: SCS; “Steelcase”) in a cash and stock transaction (the “Acquisition”). In connection with the Acquisition, HNI previously announced the commencement of an offer to exchange any and all outstanding 5.125% Notes due 2029 (the “Existing Steelcase Notes”), as issued by Steelcase, for up to $450,000,000 aggregate principal amount of new notes to be issued by HNI (the “New HNI Notes”)...
GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, BC / ACCESS Newswire / December 5, 2025 / GMV Minerals Inc. (the "Company" or "GMV") (TSXV:GMV)(OTCQB:GMVMF) is pleased to announce a non-brokered private placement of up to 20,000,000 units (each, a "Unit") at a price of C$0.20 per Unit for aggregate gross proceeds of up to C$4,000,000 (the "Offering")...
AMC Entertainment Holdings, Inc. Transfers the Majority of its Equity Investment in Hycroft Mining Holding Corporation to Sprott Mining for a Net Consideration of $24.1 million
LEAWOOD, Kan.--(BUSINESS WIRE)---- $AMC--AMC Entertainment Holdings, Inc. (NYSE: AMC) (“AMC” or “the Company”), today announced that it has completed a transaction to transfer the majority of its equity investment in Hycroft Mining Holding Corporation (Nasdaq: HYMC) (“Hycroft”) to Sprott Mining, a private Canadian corporation owned by one of the world's leading gold and silver investors, Eric Sprott. Under the terms of the private transaction, AMC sold approximately 2.34 million shares of Hycroft common...
Cyclum NextGen Travel Centers Continues with Phillips 66 for Historic Snowball Derby
PENSACOLA, Fla.--(BUSINESS WIRE)--Cyclum NextGen Travel Centers is proud to return to the historic Snowball Derby at Five Flags Speedway with its driver Kole Raz for the most iconic Super Late Model race in the country. The team will showcase its branding agreement with Phillips 66 through the iconic 76 brand, featuring the 76 Renewable Diesel-branded car. Driver Kole Raz will proudly represent both brands as he takes on one of the most competitive stages in short-track racing, further streng...
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO , Dec. 5, 2025 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced that the Organization and Compensation Committee of Nektar's Board of Directors granted non-qualified stock options to purchase an aggregate of 18,310 shares of its common stock to two newly-hired employees under Nektar's 2025 Inducement Plan. Nektar's 2025 Inducement Plan was adopted by its Board of Directors on November 6, 2025 and is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Nektar (or following a bona fide period of non-employment), as an inducement material to such individual's entering into employment with Nektar, pursuant to Nasdaq Listing Rule 5635(c)(4)...
Trican Well Service Ltd. Announces Extension and Expansion of Credit Facility
Calgary, Alberta--(Newsfile Corp. - December 5, 2025) - Trican Well Service Ltd. (TSX: TCW) ("Trican" or the "Company") today announced the successful expansion and extension of its Revolving Credit Facility ("RCF").
Webus International Limited Issues Clarification on Previous Announcement Related to Expedia Group
New York, USA, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Webus International Limited (“Webus” or the “Company”) provides the following clarification regarding a press release on October 21, 2025, titled "Webus International Limited to Expand Wetour's Expedia TAAP Partnership with Integration of Expedia Group's Newly Announced AI Trip Planner and APIs." (the “Press Release”):
Nevada Sunrise Clarifies Investor Relations Agreement
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - Nevada Sunrise Metals Corporation (TSXV: NEV) (OTC Pink: NVSGF) ("Nevada Sunrise" or the "Company") announced today that at the request of the TSX Venture Exchange (the "TSXV") the Company hereby provides additional information regarding the investor relations agreement with Nicholas Winton of Toronto, Ontario (the "Agreement"), announced on November 27, 2025. Mr. Winton is an individual at arms-length to Nevada Sunrise and has been a newsletter writer since 2006 when he began the website, Hedgehog Trader GOHHT.com...
Aurania Closes Private Placement Financing
Toronto, Ontario--(Newsfile Corp. - December 5, 2025) - Aurania Resources Ltd. (TSXV: ARU) (OTCQB: AUIAF) (FSE: 20Q) ("Aurania" or the "Company") announces that further to its news release dated November 21, 2025, the Company has closed its previously announced non-brokered private placement for gross proceeds of C$771,776.92 raised through the issuance of 6,431,466 units of the Company (the "Units") at a price of C$0.12 per Unit (the "Offering")...
STUB Investors Have Opportunity to Lead StubHub Holdings, Inc. Securities Lawsuit
NEW YORK , Dec. 5, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of StubHub Holdings, Inc. (NYSE: STUB) pursuant and/or traceable to the Registration Statement issued in connection with StubHub's September 2025 initial public offering (the "IPO"), of the important January 23, 2026 lead plaintiff deadline. So what: If you purchased StubHub common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement...
CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
NEW YORK , Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range...
Emera Renews At-The-Market Equity Program
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Emera Incorporated (“Emera” or the “Company”) (TSX/NYSE: EMA) announced today that it has renewed its at-the-market equity program (the “ATM Program”) that allows the Company to issue up to C$600,000,000 of common shares (the “Common Shares”) from treasury to the public from time to time at varying prices, at the Company's discretion. Any Common Shares sold in the ATM Program will be sold through the Toronto Stock Exchange (the “TSX”), the New York Stock E...
Greencastle Announces Closing of Acquisition of Common Shares of Royal Uranium
Toronto, Ontario--(Newsfile Corp. - December 5, 2025) - Greencastle Resources Ltd. (TSXV: VGN) ("Greencastle" or the "Company") is pleased to announce that it has closed its previously announced acquisition (the "Acquisition") of an aggregate of 500,000 common shares (the "Purchased Shares") in the capital of Royal Uranium Inc. ("Royal Uranium") pursuant to a share purchase agreement dated November 18, 2025, with an arm's length third party (the "Vendor")...
New Jersey American Water Issues Statewide Mandatory Conservation Notice
Company urges customers to conserve water as New Jersey Department of Environmental Protection issues Drought Warning CAMDEN, N.J. , Dec. 5, 2025 /PRNewswire/ -- Following the New Jersey Department of Environmental Protection (NJ DEP)'s issuance of a Drought Warning today, New Jersey American Water has issued a mandatory conservation notice for all customers across the state...
Cohu to Participate in the 14th Annual NYC Summit Investor Conference
SAN DIEGO--(BUSINESS WIRE)--Cohu, Inc. (NASDAQ: COHU), a global supplier of equipment and services optimizing semiconductor manufacturing yield and productivity, today announced that management will participate in the 14th Annual NYC Summit Investor Conference, being held at Mastro's New York on Tuesday, December 16, 2025. The presentation material utilized during the NYC Summit will be made accessible on the investor page of the company's website at www.cohu.com. About The 14th Annual NYC Summ...
Blue Water Acquisition Corp. IV, Sponsored by Serial Entrepreneur Joseph Hernandez, Files $125Million IPO Registration Statement with the U.S. Securities and Exchange Commission
GREENWICH, Conn. , Dec. 5, 2025 /PRNewswire/ -- Blue Water Acquisition Corp. IV (the "Company"), a newly formed special purpose acquisition company, announced today that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) in connection with its proposed $125 million initial public offering...
Tethys Petroleum Press Release: Corporate Update
Grand Cayman, Cayman Islands--(Newsfile Corp. - December 5, 2025) - Tethys Petroleum Limited (TSXV: TPL) ("Tethys" or the "Company") is pleased to provide an update on the Company's operations in the Republic of Kazakhstan. Operations update Oil production is continuing from wells KBD-02, KBD-06, and KBD-07, with an average of about 380 tons per day over the last month...
Comcast to Participate in UBS Investor Conference
PHILADELPHIA--(BUSINESS WIRE)--Comcast Corporation (Nasdaq: CMCSA) announced that on Monday, December 8, 2025, Mike Cavanagh, President of Comcast Corporation, will participate in the UBS Global Media and Communications Conference. A live webcast of the event will be available on the Company's Investor Relations website at www.cmcsa.com on Monday, December 8, 2025, at 9:45 A.M. Eastern Time. An on-demand replay will be available shortly after the conclusion of the presentation. To automatically...
Birks Group Inc. Reports Mid-Year Fiscal 2026 Results
MONTREAL--(BUSINESS WIRE)--Birks Group Inc. (the “Company” or “Birks Group”) (NYSE American: BGI), today reported its financial results for the twenty-six-week period ended September 27, 2025. Highlights All figures presented herein are in Canadian dollars. For the twenty-six-week period ended September 27, 2025 (“Fiscal 2026”), the Company reported net sales of $93.1 million, an increase of $13.0 million or 16.2% from the comparable prior period ended September 28, 2024 (“Fiscal 2025”). Compar...
Copper Property CTL Pass Through Trust Issues Monthly Reporting Package for November 2025
JERSEY CITY, N.J.--(BUSINESS WIRE)--Copper Property CTL Pass Through Trust (“the Trust”) has filed a Form 8-K containing its monthly report for the period ended November 30, 2025. An aggregate total distribution of $6.8 million or $0.090060 per trust certificate will be paid on December 10, 2025, to certificateholders of record as of December 9, 2025. Additional information, including the Trust's Monthly and Quarterly Reports, as well as other filings with the Securities and Exchange Commission...
Ventas to Participate in Investor Meetings at Nareit's REITworld 2025 Annual Conference
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will participate in investor meetings at Nareit's REITworld 2025 Annual Conference (the “Nareit Conference”) on December 8-9, 2025. Written materials that the Company expects to use in connection with its participation at the Nareit Conference will be made available on the Company's website on Monday, December 8, 2025 at 8:30 a.m. Eastern Time. Such materials will be archived at ir.ven...
Power Integrations Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SAN JOSÉ, Calif.--(BUSINESS WIRE)--Power Integrations, Inc. (Nasdaq: POWI) today announced that on December 1, 2025, it granted 62,333 restricted stock units (RSUs) and 1,427 performance stock units (PSUs) at target to Julie Currie, who began her employment as the company's chief people and transformation officer in November 2025. The grants were issued pursuant to Power Integrations' 2025 Inducement Award Plan. The RSUs will vest annually over three years, subject to continued service through...
Predictmedix AI Announces Closing of Final Tranche of Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - December 5, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), an emerging leader in AI-powered health and safety technology, is pleased to announce that it has successfully closed the final tranche of its non-brokered private placement (the "Offering"). In this final tranche, the Company issued 3,050,000 units ("Units") at a price of $0.05 per Unit, for gross proceeds of $152,500, bringing the total capital raised across all tranches of the Offering to $612,650...
Signature Resources Announces Results of the 2025 Annual General & Special Meeting of Shareholders and Provides Update on Winter Drill Program
Toronto, Ontario--(Newsfile Corp. - December 5, 2025) - Signature Resources Ltd. (TSXV: SGU) (OTCQB: SGGTF) (FSE: 3S30) ("Signature" or the "Company") ") is pleased to announce the results of voting at its annual general and special meeting of shareholders which was held today (the "Meeting").
Colabor Group Announces Resignation of Director
SAINT-BRUNO-DE-MONTARVILLE, Quebec, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Colabor Group Inc. (TSX: GCL) (“Colabor” or the “Company”) announces that Ms. Danièle Bergeron has tendered her resignation as director of the Company, which resignation follows her acceptance of a position with a major company.
Planet Fitness Prices $750 Million Securitized Financing Facility
HAMPTON, N.H. , Dec. 5, 2025 /PRNewswire/ -- Planet Fitness, Inc. (NYSE: PLNT) (together with its subsidiaries, the "Company") today announced that it has priced $750 million of Series 2025-1 Class A-2 Fixed Rate Senior Secured Notes (the "Class A-2 Notes"), which consist of two tranches: the Class A-2-I Senior Secured Notes with an anticipated repayment term of five years, with an aggregate principal amount of $400 million and a fixed interest rate of 5.274% per annum, payable quarterly, and the Class A-2-II Senior Secured Notes with an anticipated repayment term of seven years, with an aggregate principal amount of $350 million and a fixed interest rate of 5.649% per annum, payable quarterly...
Sable Announces Adoption of New Equity Incentive Plan
VANCOUVER, British Columbia, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Sable Resources Ltd. (“Sable” or the “Company”) (TSXV: SAE | OTCQB: SBLRF) is pleased to announce that the shareholders of the Company provided near unanimous approval of a new omnibus equity incentive plan (the “Equity Incentive Plan”) at the Company's annual general and special meeting of shareholders held earlier today (the “Meeting”). All other matters advanced at the Meeting, including setting the board at five members, re-election of directors and appointment of BDO Canada LLP as auditor, were also approved near unanimously...
AES Announces Quarterly Dividend
ARLINGTON, Va. , Dec. 5, 2025 /PRNewswire/ -- The Board of Directors of The AES Corporation (NYSE: AES) declared a quarterly common stock dividend of $0.17595 per share payable on February 13, 2026 to shareholders of record at the close of business on January 30, 2026.
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification
Vancouver, Canada, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, announced today that on December 4, 2025, the Company received a written notice from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2), as the Company's closing bid price for its common shares was below $1.00 per share for the last 30 consecutive business days...
Fly-E Group, Inc. Announces Receipt of Delinquency Notice from Nasdaq Regarding Delayed Form 10-Q
NEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Fly-E Group, Inc. (NASDAQ: FLYE, the “ Company ”), an electric vehicle company engaged in designing, installing, selling and renting smart electric motorcycles, electric bikes, and electric scooters, announced today that on November 25, the Company received a written notice (the “Notice”) from the Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that it currently does not satisfy Listing Rule 5250(c)(1), as a result of not having timely filed with the U.S. Securities and Exchange Commission (the “Commission”) its Form 10-Q for the period ended September 30, 2025 (the “Form 10-Q”)...
Skyharbour Closes $2.1 Million Private Placement of Flow-Through Shares
Vancouver, BC, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (the “ Company ”) is pleased to announce that it has closed a non-brokered private placement (the “Private Placement”) financing for total gross proceeds of CAD $2,103,898.94. The Private Placement was mostly subscribed for by several strategic institutional investors. The funds will be applied towards the Company's upcoming 2026 exploration campaign including exploration and drilling at its co-flagship Russell (“RL”) and Moore Lake Uranium Projects...
Diamond Estates Wines & Spirits Announces Share Issuances
Niagara-on-the-Lake, Ontario--(Newsfile Corp. - December 5, 2025) - Diamond Estates Wines & Spirits Inc. (TSXV: DWS) ("Diamond Estates" or the "Company") announces that today the Company issued 679,928 common shares in the capital of the Company (the "Second Tranche Earnout Shares") at a deemed issuance price of $0.21 per share as part of the purchase price of the acquisition of Perigon Beverage Group ("Perigon"). This is the second of three share issuances to the principals of Perigon based on the gross margin six-month earnouts set out in the definitive purchase agreement dated September 12, 2024 with Perigon...
Restart Life Sciences Announces Closing First Tranche of Financing
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") announces that further to its news release dated November 12, 2025, the Company has closed the first tranche of its non-brokered private placement for total gross proceeds of CDN$500,000 (the "Placement"). Pursuant to the Placement, the Company has allotted and issued 5,000,000 units (the "Units") at a price of CDN$0.10 per Unit...
Rocket Doctor Announces Granting of RSUs and Options and a Change of CFO
Vancouver, BC, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc.'s (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that Christopher Cherry shall assume the role of Interim Chief Financial Officer, to replace David Worner, effective December 8, 2025.
LibertyStream Announces Non-Brokered LIFE Offering Up to $10,000,000
DALLAS--(BUSINESS WIRE)---- $LIB.v #criticalminerals--LibertyStream Infrastructure Partners Inc. (TSXV: LIB | OTCQB: VLTLF | FSE: I2D) (“LibertyStream” or the “Company”) is pleased to announce a non-brokered private placement offering (the “Offering”) of units of the Company (the “Units”) at a price of $0.65 per Unit, for aggregate proceeds of up to $10,000,000. Each Unit will be comprised of one common share of the Company (each, a “Common Share”) and one whole common share purchase warrant (each, a “Warrant”)...
G. Scott Paterson Acquires Additional FUTR Shares Triggering Early Warning Requirements
Toronto, Ontario--(Newsfile Corp. - December 5, 2025) - Mr. G. Scott Paterson ("Mr.
CyberloQ Technologies, Inc to Present at the Small Cap Growth Virtual Investor Conference December 9th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Banyan Gold Grants Incentive Stock Options
VANCOUVER, BC / ACCESS Newswire / December 5, 2025 / Banyan Gold Corp. (the "Company" or "Banyan") (TSXV:BYN)(OTCQB:BYAGF) announces the Board of Directors of the Company have granted 5,060,000 stock options to purchase 5,600,000 shares at an exercise price of $1.00 per share with a vesting period of up to 18 months with a five-year term. The stock options are being issued to consultants, employees, advisors and exploration staff of the Company...
New America Acquisition I Corp Announces Closing of $345 Million Initial Public Offering
Heavily oversubscribed offering driven by deep institutional demand; underwriters exercised full over-allotment option NEW YORK, NY / ACCESS Newswire / December 5, 2025 / New America Acquisition I Corp (NYSE:NWAXU) today announced the closing of its initial public offering of 34,500,000 units at a public offering price of $10.00 per unit, which included 30,000,000 units initially offered and sold, and an additional 4,500,000 units issued pursuant to the full exercise of the underwriters' over-allotment option. The units began trading on the New York Stock Exchange under the symbol "NWAXU" on December 4, 2025...
Stride (LRN) Lawsuit: Was 54% Crash Caused by Alleged Undisclosed Operational Failures? Hagens Berman Investigating Pending Securities Fraud Claims
Partner Reed Kathrein Scrutinizing Damages Link Between Alleged "Ghost Students" Enrollment Fraud and Disastrous Platform Upgrade SAN FRANCISCO , Dec. 5, 2025 /PRNewswire/ -- National shareholder rights law firm Hagens Berman alerts investors in Stride, Inc. (NYSE: LRN) to the ongoing securities class action against Stride and certain of executives. The suit seeks to recover the massive investor losses sustained after the purported disclosure of both alleged inflated enrollment figures and a catastrophic technology failure...
Parsons Selected As Lead Designer For $441 Million I-70 Rocheport To Columbia Design-Build Project
CHANTILLY, Va., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the Missouri Highways and Transportation Commission has selected the Emery Sapp & Sons (ESS)-Parsons Team to deliver the Interstate 70 Rocheport to Columbia Design-Build project.
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on December 1, 2025 (the “Grant Date”), ORIC granted a total of 69,200 non-qualified stock options and 11,400 restricted stock units to three new non-executive employees who began their employment with ORIC in November 2025...
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to one new employee. Fulcrum granted stock options to purchase shares of the company's common stock pursuant to the company's 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employee entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4)...
Fermi America Executes Electric Service Agreement with Southwestern Public Service Company, a Subsidiary of Xcel Energy, Securing Up to 200 MW of Power
AMARILLO, Texas , Dec. 5, 2025 /PRNewswire/ -- Fermi America™ (Nasdaq & LSE: FRMI) today announced a signed, definitive Electric Service Agreement (ESA) with Southwestern Public Service Company (SPS), a subsidiary of Xcel Energy, to provide up to 200 megawatts (MW) of electrical capacity to Fermi's 11 GW Project Matador Campus. Under the terms of the ESA, and applicable tariffs, Xcel Energy's SPS subsidiary will begin delivering 86 MW of electrical capacity in January 2026, eventually ramping up to 200 MW...
Franklin Templeton Announces Plan to Liquidate ClearBridge Sustainable Infrastructure ETF
SAN MATEO, Calif.--(BUSINESS WIRE)--Franklin Templeton today announced it will liquidate and dissolve ClearBridge Sustainable Infrastructure ETF (INFR). The liquidation is anticipated to occur on or about January 29, 2026. The liquidation was approved by the Fund's board of trustees on December 4, 2025. After the close of business on December 31, 2025, the Funds will no longer accept creation orders. Trading in the Funds on Nasdaq Stock Market LLC (NASDAQ) will be halted prior to market open on...
Alerus Financial Corporation Declares Cash Dividend on Common Shares
MINNEAPOLIS--(BUSINESS WIRE)--Alerus Financial Corporation Declares Cash Dividend on Common Shares.
Victory Portfolios II Announces Liquidation of ETFs
SAN ANTONIO--(BUSINESS WIRE)--Victory Portfolios II today announced plans to liquidate VictoryShares WestEnd Economic Cycle Bond ETF (BMDL), VictoryShares Hedged Equity Income ETF (HEJD), and VictoryShares International Volatility Wtd ETF (CIL) (the “ETFs”). The decision to liquidate the ETFs was the result of the Company's regular review of its product lineup to ensure it is best meeting client needs. After the close of business on January 28, 2026, the ETFs will no longer accept purchase orde...
Global Mofy AI Limited Announces US$4.8 Million Private Placement Financing
BEIJING, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Global Mofy AI Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a generative AI-driven technology solutions provider engaged in virtual content production and the development of 3D digital assets for use in the broader digital content industry, today announced that it has entered into securities purchase agreements (the “SPAs”) with certain investors for a private placement of its securities for gross proceeds of approximately US$4.8 million (the “Offering”), before deducting professional fees and other offering expenses...
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 67,483 shares of common stock. Awards were made to nine new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company's Compensation Committe...
Johnson & Johnson's INLEXZO™ (gemcitabine intravesical system) delivers 74 percent disease-free survival at one year in BCG-unresponsive, high-risk, papillary-only NMIBC
New data from Cohort 4 of the SunRISe-1 study show more than 95 percent of patients remained progression free at one year, with more than 92 percent not undergoing bladder removal Patients with this type of bladder cancer have limited choices beyond radical cystectomy, highlighting the need for newer therapies for bladder preservation RARITAN, N.J. , Dec. 5, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) announced today that new data from the investigational Cohort 4 of the Phase 2b SunRISe-1 study show treatment with gemcitabine intravesical system resulted in high one-year disease-free survival (DFS), progression-free survival (PFS), and overall survival (OS) rates in patients with Bacillus Calmette-Guérin (BCG)-unresponsive, high-risk, papillary-only non-muscle invasive bladder cancer (NMIBC).1 These data were featured as a late-breaking oral presentation at the Society of Urologic Oncology (SUO) 2025 Annual Meeting and build upon data presented at the 2025 American Urological Association (AUA) Annual Meeting...
FCPT Announces Acquisition of a Baptist Health Property for $4.7 Million
MILL VALLEY, Calif.--(BUSINESS WIRE)--Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the acquisition of a Baptist Health property for $4.7 million. The property is newly constructed and located in a strong retail corridor in Alabama and is corporate-operated under a long term, net lease with approximately ten y...
Omega Flex, Inc. Announces Regular Quarterly Dividend for the Fourth Quarter 2025
EXTON, Pa., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Omega Flex, Inc. (the “Company”) (NASDAQ: OFLX) today announced that the Board of Directors declared a regular quarterly dividend of $0.34 per share payable on January 7, 2026, to shareholders of record on December 19, 2025. In determining the amount of future regular quarterly dividends, the Board will review the cash needs of the Company, and based on results of operations, financial condition, capital expenditure plans, and consideration of possible acquisitions, as well as such other factors as the Board of Directors may consider relevant, determine on a quarterly basis the amount of a regular quarterly dividend...
Quanex Building Products Declares Quarterly Dividend
HOUSTON, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced that its Board of Directors declared a quarterly cash dividend of $0.08 per share on the Company's common stock, payable December 31, 2025, to shareholders of record on December 15, 2025...
Bimergen Energy Announces Uplist to the NYSE American Stock Exchange with Concurrent Offering
Newport Beach, CA, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Bimergen Energy Corporation (OTCQB: BESS) (“Bimergen”), a utility-scale battery energy storage systems (BESS) asset owner, project developer, and independent power provider, today announced that its shares of common stock have been approved for listing on the NYSE American LLC ("NYSE American") stock exchange. Bimergen expects that its common stock will begin trading on the NYSE American under the symbol “BESS” at the opening of trading on or about December 11, 2025, subject to authorization of the application and continued compliance with the exchange rules...
Essex Property Trust Declares Quarterly Distributions
SAN MATEO, Calif.--(BUSINESS WIRE)--Essex Property Trust, Inc. (NYSE:ESS) announced today that its Board of Directors has declared a regular quarterly cash dividend of $2.57 per common share, payable January 15, 2026 to shareholders of record as of January 2, 2026. About Essex Property Trust, Inc. Essex Property Trust, Inc., an S&P 500 company, is a fully integrated real estate investment trust (“REIT”) that acquires, develops, redevelops, and manages multifamily residential properties in s...
Morningstar, Inc. Increases Quarterly Dividend to 50 Cents Per Share
CHICAGO--(BUSINESS WIRE)--The board of directors of Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment insights, today declared a quarterly dividend of 50 cents per share, an increase of approximately 10 percent. The dividend is payable Jan. 30, 2026, to shareholders of record as of Jan. 2, 2026. The 4.5 cent increase from the prior quarterly rate of 45.5 cents per share results in an annualized dividend of $2.00 per share compared with the prior annualized rate of $...